Register Now: Does Your Pharmaceutical WMS Grow with You?
News|Articles|August 1, 2024

Pharm Pulse 8/1/24: Defining the Health Equity Officer Role, How AI is Revamping the Product Launch & more

How AI is Revamping the Product Launch

New technology is allowing teams to analyze data at faster rates and make decisions much sooner than they previously could.

Depression in Women with Breast Cancer Lowers Survival

New research expands on previous knowledge that breast cancer survivors are more at risk for depression than people without breast cancer.

Microsoft’s AI Dreams Make for an Expensive Reality

As cloud growth disappoints, blowout capital spending won’t hearten investors.

Defining the Health Equity Officer Role: IHI Releases Guidance for Health Systems

New report includes actionable recommendations to support the hiring and long-term success of health equity officers.

Nicholas Saraceno on LinkedIn

In an extended version of my chat with Peter, he emphasizes a variety of points, including the need for transparency within the supply chain.

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs


Related to this article

CVS Pharmacy Sign at Storefront Entrance | © Mark Roger Bailey - stock.adobe.com 557616813
In this week’s Pharma Pulse, CVS Health plans to separate into two public companies, Bayer weighs what MFN pricing could mean for its launch strategies and an ACTO survey finds most life sciences leaders see no clear industry standard for responsible AI.